Login

David Allmond, CEO, Novacyt 00:00:00

Share On Facebook Share On Twitter

David Allmond: Discussing future infectious disease threats

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Tarek Müller, CEO of ABOUT YOU Holding SE, Discusses the Company's Rapid Growth| Tarek Müller, CEO , ABOUT YOU Holding SE.
00:00:00
Silence Therapeutics - The GOLDen future of RNAi Research - Mark Rothera, President and CEO of Silence Therapeutics
00:10:00
Lawrence Stroll Outlines Aston Martin's Ambitious Future | Lawrence Stroll, Chairman, Lawrence Stroll Aston Martin Lagonda Global Holdings PLC.
00:10:00
Ben Arnold’s Journey from UBS to Global Trading Expertise
00:00:00
Dr. Scott Cheney talks about benign prostatic hyperplasia - Scott M. Cheney, M.D.
00:10:00
Interview with Fernando Lehner, CEO of BVZ Group, on the Business | Fernando Lehner - CEO of bvz holding ag
00:10:00
BRASTER S.A mission is to create a healthier world|Dariusz Karolak, President, BRASTER S.A.
00:10:00
Paul Canvert: Driving Recruitment & Retention in Transport | Paul Sarant - CEO, MD & Executive Director of K&S Corporation Limited
00:10:00
Neal Froneman Shares Insights as CEO of Sibanye-Stillwater | Neal Froneman, CEO , Sibanye-Stillwater Ltd.
00:10:00
Sarama Resources' Strategic Plans and Investment Potential in 2020: Insights from the CEO at Cape Town Mining Conference
00:10:00
Nuclear Fuels: U.S. Focused Uranium Exploration and Production Pathway in Wyoming
00:10:00
Analyzing the European Credit Markets: Madelaine Jones on Bloomberg Markets Europe 2023

© 2026 Nehu